Iron ferrous sulfate 325 mg
Pro Research Analysisby 
Searched over 200M research papers
Iron Ferrous Sulfate 325 mg: Efficacy, Safety, and Interactions
Efficacy of Ferrous Sulfate in Treating Iron Deficiency Anemia
Chronic Kidney Disease (CKD) Patients
Ferrous sulfate is commonly used to treat iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD). A study comparing ferrous sulfate to ferric citrate in CKD patients found that while both treatments improved iron parameters, ferric citrate led to a greater increase in transferrin saturation (TSAT) and ferritin levels over 12 weeks. Another trial comparing oral ferrous sulfate to intravenous iron sucrose in CKD patients showed that intravenous iron was more effective in increasing hemoglobin levels, although it was associated with a higher risk of serious adverse events .
Postpartum Anemia
In women with postpartum anemia, ferrous sulfate was compared to intravenous ferric carboxymaltose. The study concluded that intravenous ferric carboxymaltose was more effective in rapidly increasing hemoglobin levels and was associated with fewer adverse events compared to oral ferrous sulfate.
Cancer Patients Receiving Chemotherapy
For anemic cancer patients undergoing chemotherapy, intravenous ferric gluconate was found to be more effective than oral ferrous sulfate in increasing hemoglobin levels when used alongside epoetin alfa. This suggests that intravenous iron supplementation may be more beneficial in this patient population.
Safety and Side Effects of Ferrous Sulfate
Gastrointestinal Side Effects
Ferrous sulfate is associated with significant gastrointestinal (GI) side effects. A systematic review and meta-analysis revealed that ferrous sulfate significantly increases the risk of GI side effects compared to both placebo and intravenous iron. This includes symptoms such as nausea, constipation, and abdominal discomfort, which can affect patient compliance.
Drug Interactions
Ferrous sulfate can interact with other medications, reducing their bioavailability. For instance, it significantly decreases the bioavailability of levodopa, a medication used in Parkinson's disease, likely due to chelation. Similarly, ferrous sulfate modestly reduces the bioavailability of gemifloxacin, an antibiotic, when taken together.
Special Considerations
Cystic Fibrosis Patients
In cystic fibrosis patients with hypoferremic anemia, ferrous sulfate increased serum iron and TSAT but did not significantly affect hemoglobin levels or respiratory health over a 6-week period. This suggests that while ferrous sulfate can improve iron parameters, its impact on anemia and overall health in cystic fibrosis patients may be limited.
Restless Legs Syndrome
A study on the use of ferrous sulfate for treating restless legs syndrome found no significant improvement in symptoms compared to placebo, indicating that ferrous sulfate may not be effective for this condition.
Conclusion
Ferrous sulfate 325 mg is an effective treatment for iron deficiency anemia in various patient populations, including those with CKD and postpartum anemia. However, its use is associated with significant gastrointestinal side effects and potential drug interactions. Intravenous iron formulations may offer superior efficacy and tolerability in certain cases, such as in cancer patients receiving chemotherapy. Careful consideration of the patient's overall health and potential interactions is essential when prescribing ferrous sulfate.
Sources and full results
Most relevant research papers on this topic